FEMASYS INC

FEMY Nasdaq CIK: 0001339005

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 3950 JOHNS CREEK COURT, SUWANEE, GA, 30024
Mailing Address 3950 JOHNS CREEK COURT, SUWANEE, GA, 30024
Phone 770-500-3910
Fiscal Year End 1231
EIN 113713499

Financial Overview

FY2025

Recent SEC Filings

Form Type Date Filed Document
DEF 14A Definitive proxy statement April 6, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
8-K Current report of material events April 1, 2026 View on SEC
3 Initial insider ownership report April 1, 2026 View on SEC
10-K Annual financial report March 31, 2026 View on SEC
8-K Current report of material events March 31, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC
4 Insider stock transaction report March 27, 2026 View on SEC

Annual Reports

10-K March 31, 2026
  • Transitioning from R&D to commercial stage with FDA-cleared FemaSeed
  • Strong intellectual property portfolio with over 175 patents
View Analysis

Material Events

8-K Financial Distress January 15, 2026
High Impact
  • FEMASYS has secured a second 180-day extension from Nasdaq to regain compliance with the minimum bid price rule.
  • The new deadline for FEMASYS to achieve compliance is July 13, 2026.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.